Karman Wins $21.3M Navy Torpedo Contract, But Fundamentals Remain Weak

What happened

Karman announced a $21.3 million contract from Northrop Grumman for the Proof of Manufacture phase of the U.S. Navy MK 54 Torpedo Fleet Exercise Section. While this award extends Karman's relationship with a key prime and adds to its backlog, it is a modest sum relative to the company's $345 million annual revenue and $8.6 billion market cap. The company's financial health remains precarious: GAAP net income is thin, operating cash flow was negative for the first nine months of 2025, and net debt-to-EBITDA stands at 4.5x. At roughly 435x trailing EPS and 94x EV/EBITDA, the stock prices in many years of flawless execution and benign defense budgets. This single contract does not address the fundamental disconnect between valuation and cash generation.

Implication

While the win underscores Karman's entrenched positions on Navy programs, it does not alter the bearish thesis. Investors need sustained improvement in cash conversion and deleveraging before considering the stock; this news alone does not warrant a change in stance.

Thesis delta

This incremental contract win does not shift the fundamental thesis. The core risks of high valuation, leverage, and weak cash flow remain unchanged. The STRONG SELL rating persists, as the contract is too small to materially improve financial metrics or close the gap between market price and intrinsic value.